Pharmacologic Reversal Agents for Hemorrhagic Stroke: What ICU Nurses Must Know

Activity Summary

Acute hemorrhagic stroke patients are often admitted to the ICU due to an increased risk of further bleeding, deterioration and mortality. Pharmacologic reversal agents for acute hemorrhages are often used as initial interventions. This presentation provides a high-level overview of acute hemorrhagic stroke. Critical care nurses must have an intermediate and proficient level of understanding of the use of pharmacologic reversal agents in the management of acute hemorrhagic strokes.

Objectives

Discuss the risk factors and mechanisms for acute hemorrhagic stroke.
Summarize the pharmacology of reversal agents used for acute hemorrhagic stroke.
Identify the appropriate pharmacologic reversal agents for acute hemorrhagic stroke.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.